Amiodarone-induced multiple organ damage in an Alström syndrome patient with end-stage renal disease and hepatic cirrhosis
Authors:
- Tadashi YoshidaTadashi Yoshida
- Satomi NishiSNSatomi Nishi
- 5 July 2021
- journal article
- case report
- Published by Springer Nature in CEN Case Reports
- Vol. 11 (1) , 11-16
Abstract
Alström syndrome (AS) is an extremely rare disease accompanied by blindness, hearing loss, obesity, type 2 diabetes, dilated cardiomyopathy, and progressive hepatic and renal dysfunction. The life span of AS patients rarely exceeds 50 years, and thus there are very few reports describing the implementation of renal replacement therapy for these patients. We here report a case of AS patient who exhibited dilated cardiomyopathy, end-stage renal disease, and hepatic cirrhosis. He underwent hemodialysis therapy more than 3 years. Although he eventually died of amiodarone-induced multiple organ damage in the lungs and liver, the present case suggests that hemodialysis therapy can be a choice of renal replacement therapy for AS patients with end-stage renal disease.Keywords
This publication has 15 references indexed in Scilit:
- Kidney Transplantation in Alström Syndrome: Case ReportTransplantation Proceedings, 2017
- Alstrom Syndrome: Genetics and Clinical OverviewCurrent Genomics, 2011
- ALMS1-Deficient Fibroblasts Over-Express Extra-Cellular Matrix Components, Display Cell Cycle Delay and Are Resistant to ApoptosisPLOS ONE, 2011
- Alström syndrome: insights into the pathogenesis of metabolic disordersNature Reviews Endocrinology, 2010
- Amiodarone Pulmonary ToxicityCanadian Respiratory Journal, 2009
- Alström SyndromeEuropean Journal of Human Genetics, 2007
- New Alström Syndrome Phenotypes Based on the Evaluation of 182 CasesArchives of internal medicine (1960), 2005
- Hepatic dysfunction in two sibs with Alström syndrome: Case report and review of the literatureAmerican Journal of Medical Genetics, 1997
- Amiodarone lung: Pathologic finding in clinically toxic patientsHuman Pathology, 1987
- Steady-State Serum Amiodarone Concentrations: Relationships with Antiarrhythmic Efficacy and ToxicityAnnals of Internal Medicine, 1984